FGF21 and fatty liver disease: Utilizing a liver-specific KLB knockdown mouse model, we further confirmed this association, highlighting the profound impact of KLB deficiency in limiting KD’s improvement of hepatic steatosis, suggesting the indispensability of the liver FGF21-KLB pathway.